← Open Payments lookup

ORCHID MESIAS: Open Payments

NPI 1710627880 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$370 in 10 payments from 9 companies in 2025. Trend: 2023 $561 · 2024 $511 · 2025 $370

Food & beverage: $370
CompanyPaymentsAmount
Novo Nordisk Inc1$121
Globus Medical, Inc.1$69
Lilly USA, LLC2$50
Bayer Healthcare Pharmaceuticals Inc.1$30
Cranial Technologies, Inc1$25
Merck Sharp & Dohme LLC1$24
Collegium Pharmaceutical, Inc.1$20
Seqirus USA Inc1$17
Aimmune Therapeutics, Inc.1$15

Products named: Ozempic, Senza, MOUNJARO, Kerendia, Doc Band, ROTATEQ, Belbuca, JARDIANCE.

Industry payments across MD — which companies pay providers there.